
Zydus Cadila last month had said that it has applied for emergency use authorisation (EUA) with the Indian Drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture 10-12 crore doses annually.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3itqBVI
via
IFTTT
0 comments:
Post a Comment